Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-27 @ 11:33 PM
Study NCT ID:
NCT00064233
Status:
COMPLETED
Last Update Posted:
2020-08-03
First Post:
2003-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11
Start Date Type:
None
Primary Completion Date:
2006-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-10
Completion Date Type:
ACTUAL
First Submit Date:
2003-07-08
First Submit QC Date:
None
Study First Post Date:
2003-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-30
Last Update Post Date:
2020-08-03
Last Update Post Date Type:
ACTUAL